Health Care Reform and Disparities in the Care and Outcomes of Trauma Patients

医疗保健改革以及创伤患者护理和结果的差异

基本信息

  • 批准号:
    8449532
  • 负责人:
  • 金额:
    $ 37.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-06-09 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Health Care Reform (HCR) is of paramount importance to the national agenda. This project will analyze the impact of Massachusetts (MA) HCR on disparities in the delivery and quality of trauma care and identify changes in care delivery infrastructure and policies that are critical for quality improvement, cost reduction and ultimate elimination of those disparities. Traumatic injuries are the leading cause of potential years of life lost before age 65 in MA and in the U.S. Each year in MA, trauma claims nearly 2,000 lives, and is associated with around 53,000 inpatient hospitalizations, and more than $2.5 billion acute care hospital charges. Previous analysis of pre-HCR MA healthcare data documented significant geographic, socioeconomic and racial/ethnic disparities in the delivery and outcomes of trauma care. This proposed investigation will focus on 5 groups of outcomes and quality indicators that are of clinical and policy significance, including 1) utilization, 2) mortality, 3) quality indicators, 4) discharge dispositions, and 5) cost of trauma care. Multi-level models will be used to analyze data routinely collected by MA government agencies between 2002 and 2011, including 1) Trauma Surveillance Systems, 2) Emergency Department Discharge Database, 3) Inpatient Hospital Discharge Database, 4) Outpatient Observation Stay Database, 5) Registry of Vital Records and Statistics, and 6) All Payers Claims Database. These databases are mandated by MA legislature. The specific aims are: Aim 1: To determine the predictors, extent and temporal changes of disparities in the 5 groups of key outcomes and quality indicators, before and after the implementation of MA HCR; Aim 2: To determine the impact of MA HCR on the reduction of these disparities by comparing disparity indices and their components before and after the HCR, and Aim 3: To develop evidence-based recommendations on critical changes in infrastructure and trauma care policies to improve outcomes and eliminate disparities when HCR is already in place. The MA HCR law was enacted in 2006 to provide universal access to medical care and to improve health. However, little is known about whether this has actually improved health care utilization by economically marginalized populations, reduced disparities in the quality of care, and consequently improved health outcome. To our knowledge, such an investigation has not been carried out. This proposed investigation will thus fill a critical knowledge gap on the role of HCR in eliminating health care disparities by providing timely, unique, and valuable information to the current policy debate on national HCR.
描述(由申请人提供):卫生保健改革(HCR)对国家议程至关重要。该项目将分析马萨诸塞州(MA)HCR对创伤护理提供和质量方面的差异的影响,并确定护理提供基础设施和政策方面的变化,这些变化对于提高质量、降低成本和最终消除这些差异至关重要。在马萨诸塞州和美国,创伤是导致65岁之前潜在寿命损失的主要原因。在马萨诸塞州,创伤每年夺走近2000人的生命,与大约5.3万名住院患者和超过25亿美元的急性护理医院费用有关。以前对HCR-MA前医疗保健数据的分析记录了创伤护理的提供和结果方面存在显著的地理、社会经济和种族/民族差异。这项拟议的调查将集中于具有临床和政策意义的5组结果和质量指标,包括1)利用率、2)死亡率、3)质量指标、4)出院处置和5)创伤护理费用。多层次模型将用于分析MA政府机构在2002至2011年间收集的常规数据,包括1)创伤监测系统,2)急诊科出院数据库,3)住院出院数据库,4)门诊观察停留数据库,5)生命记录和统计登记表,6)所有付款人索赔数据库。这些数据库是由MA立法机构授权的。具体目标是:目标1:确定五组主要成果和质量指标实施前后差异的预测因素、程度和时间变化;目标2:通过比较差异指数及其组成部分,确定管理和健康状况报告对缩小这些差异的影响;目标3:就基础设施和创伤护理政策的关键变革提出循证建议,以改善成果并消除已有的差异。2006年颁布了MA HCR法,以提供普遍获得医疗保健和改善健康的机会。然而,很少有人知道这是否真的改善了经济边缘人群的保健利用情况,缩小了保健质量上的差距,从而改善了健康结果。据我们所知,还没有进行过这样的调查。因此,这项拟议的调查将通过为当前关于国家卫生改革的政策辩论提供及时、独特和有价值的信息,填补关于卫生政策改革在消除卫生保健差距方面的作用的关键知识空白。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Survival Rates in Trauma Patients Following Health Care Reform in Massachusetts.
马萨诸塞州医疗保健改革后创伤患者的生存率。
  • DOI:
    10.1001/jamasurg.2014.2464
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    16.9
  • 作者:
    Osler,Turner;Glance,LaurentG;Li,Wenjun;Buzas,JefferyS;Hosmer,DavidW
  • 通讯作者:
    Hosmer,DavidW
Re: Trauma care does not discriminate: The association of race and health insurance with mortality following traumatic injury.
回复:创伤护理不歧视:种族和健康保险与创伤后死亡率的关系。
  • DOI:
    10.1097/ta.0000000000000779
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Osler,Turner;Glance,LaurentG;Li,Wenjun;Buzas,JefferyS;Wetzel,MeganL;Hosmer,DavidW;Millham,Frederick
  • 通讯作者:
    Millham,Frederick
Impact of Risk Adjustment for Socioeconomic Status on Risk-adjusted Surgical Readmission Rates.
  • DOI:
    10.1097/sla.0000000000001363
  • 发表时间:
    2016-04
  • 期刊:
  • 影响因子:
    9
  • 作者:
    Glance LG;Kellermann AL;Osler TM;Li Y;Li W;Dick AW
  • 通讯作者:
    Dick AW
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wenjun Li其他文献

Wenjun Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wenjun Li', 18)}}的其他基金

Social and behavioral determinants of MOUD utilization and opioid overdose
MOUD 使用和阿片类药物过量的社会和行为决定因素
  • 批准号:
    10664099
  • 财政年份:
    2023
  • 资助金额:
    $ 37.36万
  • 项目类别:
Neighborhood Risk Factors for Falls in the Elderly
老年人跌倒的社区危险因素
  • 批准号:
    10396681
  • 财政年份:
    2020
  • 资助金额:
    $ 37.36万
  • 项目类别:
Neighborhood Risk Factors for Falls in the Elderly
老年人跌倒的社区危险因素
  • 批准号:
    10625284
  • 财政年份:
    2020
  • 资助金额:
    $ 37.36万
  • 项目类别:
Neighborhood Risk Factors for Falls in the Elderly
老年人跌倒的社区危险因素
  • 批准号:
    10342708
  • 财政年份:
    2020
  • 资助金额:
    $ 37.36万
  • 项目类别:
Microsurgery Core
显微外科核心
  • 批准号:
    10625535
  • 财政年份:
    2015
  • 资助金额:
    $ 37.36万
  • 项目类别:
Microsurgery Core
显微外科核心
  • 批准号:
    10024443
  • 财政年份:
    2015
  • 资助金额:
    $ 37.36万
  • 项目类别:
Microsurgery Core
显微外科核心
  • 批准号:
    10197015
  • 财政年份:
    2015
  • 资助金额:
    $ 37.36万
  • 项目类别:
Microsurgery Core
显微外科核心
  • 批准号:
    10619066
  • 财政年份:
    2015
  • 资助金额:
    $ 37.36万
  • 项目类别:
Health Care Reform and Disparities in the Care and Outcomes of Trauma Patients
医疗保健改革以及创伤患者护理和结果的差异
  • 批准号:
    8154107
  • 财政年份:
    2011
  • 资助金额:
    $ 37.36万
  • 项目类别:
Health Care Reform and Disparities in the Care and Outcomes of Trauma Patients
医疗保健改革以及创伤患者护理和结果的差异
  • 批准号:
    8278550
  • 财政年份:
    2011
  • 资助金额:
    $ 37.36万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.36万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.36万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 37.36万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.36万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 37.36万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.36万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.36万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.36万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 37.36万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 37.36万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了